Chopas James George 4
4 · Apellis Pharmaceuticals, Inc. · Filed Jan 21, 2026
Research Summary
AI-generated summary of this filing
Apellis (APLS) VP/Chief Accounting Officer James Chopas Sells 726 Shares
What Happened James George Chopas, VP and Chief Accounting Officer of Apellis Pharmaceuticals (APLS), disposed of 726 shares in an open-market sale on January 20, 2026. The shares were sold at $19.79 each for total proceeds of $14,370. This was a sale to satisfy tax withholding obligations on recently released restricted stock units, an administrative (not necessarily sentiment-driven) transaction.
Key Details
- Transaction date and price: 2026-01-20 — 726 shares sold at $19.79 per share.
- Total proceeds: $14,370.
- Shares owned after transaction: Not disclosed on this Form 4.
- Footnote: F1 — "This represents shares sold to cover tax withholding on the Restricted Stock Units released on January 16, 2026."
- Filing date and timeliness: Form filed 2026-01-21 for a 2026-01-20 transaction; appears to be filed timely.
Context This sale was recorded as tax-withholding related to RSU vesting (code F), a routine administrative action that does not necessarily indicate the insider's view on the company's outlook.
Insider Transaction Report
Form 4
Chopas James George
VP/Chief Accounting Officer
Transactions
- Sale
Common Stock
[F1]2026-01-20$19.79/sh−726$14,370→ 51,869 total
Footnotes (1)
- [F1]This represents shares sold to cover tax withholding on the Restricted Stock Units released on January 16, 2026.
Signature
/s/ David Watson, attorney-in-fact for James Chopas|2026-01-21